|
⚲
|
| Keyboard |
| David Jorden | |
|---|---|
| Firm | |
| Address | 8285 El Rio Suite 190 Houston, TX 77054 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| NUO Therapeutics Inc | 021-553598 | Executive Officer | 0.8 M of 0.8 M |
||
| NUO Therapeutics Inc | 021-524645 | Executive Officer | 0.8 M of 0.8 M |
||
| NUO Therapeutics Inc | 021-513970 | Executive Officer | 0.7 M of 0.7 M |
||
| NUO Therapeutics Inc | 021-500556 | Executive Officer | 1.0 M of 1.0 M |
||
| NUO Therapeutics Inc | 021-489113 | Executive Officer | 1.0 M of 1.0 M |
||
| Nanospectra Biosciences Inc | 021-475955 | Executive Officer | 6.1 M of 10.1 M |
||
| NUO Therapeutics Inc | 021-446304 | Executive Officer | 0.4 M of 0.4 M |
||
| NUO Therapeutics Inc | 021-444862 | Executive Officer | 3.5 M of 3.5 M |
||
| Nanospectra Biosciences Inc | 021-375044 | Executive Officer | 8.6 M of 11.3 M |
||
| NUO Therapeutics Inc | 021-314431 | Executive Officer | 0.5 M of 0.5 M |
||
| PLX Pharma Inc | 021-289624 | Executive Officer | 18.2 M of 18.2 M |
||
| Nanospectra Biosciences Inc | 021-280450 | Executive Officer | 2.0 M of 4.2 M |
||
| NUO Therapeutics Inc | 021-263573 | Executive Officer | 7.5 M of 10.5 M |
||
| PLX Pharma Inc | 021-259059 | Executive Officer | 1.3 M of 2.0 M |
||
| Nanospectra Biosciences Inc | 021-253113 | Executive Officer | 0.9 M of 1.2 M |
||
| Nanospectra Biosciences Inc | 021-223887 | Executive Officer | 0.8 M of 0.8 M |
||
| Cytomedix Inc | 021-207744 | Director | 3.0 M of 3.0 M |
||
| PLX Pharma Inc | 021-199168 | Director | 9.0 M of 9.0 M |
||
| Nanospectra Biosciences Inc | 021-198131 | Executive Officer | 0.5 M of 0.7 M |
||
| Nanospectra Biosciences Inc | 021-197405 | Executive Officer | 1.6 M of 1.6 M |
||
| Nanospectra Biosciences Inc | 021-197406 | Executive Officer | 0.8 M of 0.8 M |
||
| PLX Pharma Inc | 021-193567 | Director | 8.3 M of 8.3 M |
||
| Opexa Therapeutics Inc | 021-192005 | Executive Officer | |||
| Opexa Therapeutics Inc | 021-192004 | Executive Officer | 0.7 M of 0.7 M |
||
| Opexa Therapeutics Inc | 021-187179 | Executive Officer | of 15.0 M |
||
| Opexa Therapeutics Inc | 021-181897 | Director | 4.1 M of 4.1 M |
||
| Cytomedix Inc | 021-173531 | Director | 21.0 M of 21.0 M |
||
| PLX Pharma Inc | 021-166758 | Director | 2.9 M of 7.0 M |
||
| Cytomedix Inc | 021-163474 | Director | 1.3 M of 1.3 M |
||
| Cytomedix Inc | 021-163473 | Director | 0.6 M of 0.6 M |
||
| Cytomedix Inc | 021-159274 | Director | 0.3 M of 0.3 M |
||
| Cytomedix Inc | 021-149299 | Director | 0.1 M of 10.0 M |
||
| PLX Pharma Inc | 021-146099 | Director | 2.0 M of 6.0 M |
||
| Cytomedix Inc | 021-140962 | Director | 3.6 M of 3.6 M |
||
| PLX Pharma Inc | 021-65821 | Director | 3.1 M of 3.1 M |
||
| Opexa Therapeutics Inc | 021-70270 | Director | 1.1 M of 2.0 M |
||